B · Normal
On August 27, RevMed priced pancreatic cancer drugs at $39,800 per month.
Related telegraphs
8月27日电，英伟达表示，Vera Rubin现已全面投入生产。
08-27 04:25
8月27日电，英伟达盘后一度跌约3%，现跌幅收窄至0.6%。
08-27 04:24
On August 27, Hewlett-Packard Co. fell more than 10% after the closing bell. The
08-27 04:19
[HP raises fourth-quarter performance outlook] On August 27, HP's third-quarter
08-27 04:17
On August 27, Synopsys’ revenue in the third fiscal quarter was US$2.48 billion,
08-27 04:15
[Barclays: The U.S. Treasury market can digest a larger scale of Treasury repurc
08-27 04:13
Comments